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Synthetic cannabinoids JWH-018, JWH-073 and AM2201 were
metabolised by the fungus Cunninghamella elegans. In this article,
data on individual metabolites of their retention times, mass
accuracies, major product ions and structures indicated by product
ions are presented. The data in this article is related to “Bio-
transformation of synthetic cannabinoids JWH-018, JWH-073 and
AM2201 by Cunninghamella elegans” [1].
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
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acquiredLiquid chromatography -tandem mass spectrometry (Agilent 1290 LC system
coupled to Agilent 6490 Triple Quadrupole mass spectrometer), high reso-
lution quadrupole Time-of-Flight mass spectrometry (Agilent 6510 Accurate
Mass QToF Mass Spectrometer)ata format Analysed
xperimental
factorsSamples were extracted by dichloromethane.xperimental
featuresLiquid chromatography-tandem mass spectrometry analysis of fungal
metabolites of synthetic cannabinoids JWH-018, JWH-073 and AM2201ata source location Sydney, Australia
ata accessibility Data are available with this articleValue of the data Chromatographic and mass spectrometric data on individual metabolites are provided for
reference.
 Product ions indicative of the structures of metabolites are listed.
 The data can be compared with human or other in vitro metabolism.1. Data
Tables 1, 3 and 5 list all the metabolites with biotransformation, retention time, observed accurate
mass, formula and major product ions of JWH-018, JWH-073 and AM2201, respectively. Product ions
representative of structures for JWH-018, JWH-073 and AM2201 metabolites are presented in
Tables 2, 4, and 6, respectively. Overlaid extracted ion chromatograms of all the metabolites of JWH-
018, JWH-073 and AM2201 are shown in Fig. 2 of Ref. [1] with annotated metabolite identiﬁcation
(ID) names (Tables 1–6).2. Experimental design, materials and methods
2.1. Chemicals
JWH-018 and JWH-073 were synthesized in-house following previously reported methods and
characterized by mass spectrometry (MS) and 1D, 2D nuclear magnetic resonance (NMR) spectro-
scopy [3,4]. AM2201 (purity 99.4%) was obtained from the National Measurement Institute (North
Ryde, NSW, Australia). Reference standards JWH-018 N-(4-hydroxypentyl), JWH-018 N-(5-hydro-
xypentyl), JWH-018 N-pentanoic acid, JWH-073 N-(3-hydroxybutyl), JWH-073 N-(4-hydroxybutyl)
and JWH-073 N-butanoic acid were obtained from PM separations (Capalaba, QLD, Australia). Reagent
grade dichloromethane, methanol, KH2PO4, NaCl and LC grade acetonitrile and methanol were
obtained from Chemsupply (Gilman, SA, Australia). Potato dextrose agar, glucose, peptone, and yeast
extract were purchased from Oxoid Australia (Adelaide, SA, Australia).
2.2. Microbial culture and biotransformation conditions
Cultures of C. elegans ATCC 10028b (Cryosite Ltd, South Granville, NSW, Australia) were propagated
on potato dextrose agar plates at 27 °C for 5 days. The mycelia from ﬁve plates were then transferred
to 20 mL of sterile physiological saline solution and homogenized for 5 min. Approximately 3 mL
aliquots of the homogenate were used to inoculate 250 mL Erlenmeyer ﬂasks containing 100 ml of
growth media. The cultures were incubated for 48 h at 26 °C on an Infors HT Multitron rotary shaker
Table 1
Metabolites of JWH-018 after C. elegans incubation.
ID Biotransformation RT,
min
m/z
[MþH]þ
Mass accu-
racy (ppm)
Formula Major product
ions
Ma1 Dihydrodiol formationþN-dealkylation 8.0 306.1123 0.7 C19H15NO3 143, 144, 171,
189
Ma2 Dihydrodiol formationþhydroxylation at pentyl
side chain
8.5 392.1852 1.0 C24H25NO4 143, 144, 171,
189, 230, 374
Ma3 Dihydrodiol formationþhydroxylation at pentyl
side chain
9.2 392.1850 1.6 C24H25NO4 143, 144, 171,
189, 230, 374
Ma4 Dihydrodiol formationþketone formation at
pentyl side chain
9.3 390.1694 1.4 C24H23NO4 143, 144, 171,
189, 228
Ma5 Dihydrodiol formationþketone formation at
pentyl side chain
10.3 390.1695 1.1 C24H23NO4 143, 144, 171,
189, 228
Ma6 Dihydroxylation at pentyl side chain and naph-
thalene moiety
12.5 374.1745 1.5 C24H23NO3 143, 144, 171,
230
Ma7 Dihydroxylation at pentyl side chain 12.8 374.1745 1.6 C24H23NO3 127, 144, 155,
246
Ma8 Dihydroxylation at pentyl side chain and naph-
thalene moiety
13.1 374.1746 1.3 C24H23NO3 143, 144, 171,
230
Ma9 Dihydroxylation at pentyl side chain and naph-
thalene moiety
14.1 374.1746 1.3 C24H23NO3 143, 144, 171,
230
Ma10 Ketone formation at pentyl side
chainþhydroxylation at naphthalene moiety
14.5 372.1590 1.0 C24H21NO3 143, 144, 171,
228
Ma11 Dihydroxylation at pentyl side chain and naph-
thalene moiety
14.9 374.1745 1.5 C24H23NO3 143, 144, 171,
230
Ma12 Dihydrodiol formation 16.1 376.1901 1.6 C24H25NO3 143, 171, 189,
214
Ma13 Carboxylation (N-pentanoic acid)a 16.4 372.1591 0.9 C24H21NO3 127, 144 155 244
Ma14 Hydroxylation at pentyl side chain (5-
hydroxypentyl)a
17.2 358.1796 1.6 C24H23NO2 127, 144, 155,
230
Ma15 Hydroxylation at pentyl side chain (4-
hydroxypentyl)a
17.6 358.1798 1.0 C24H23NO2 127, 144, 155,
230
Ma16 Hydroxylation at pentyl side chain 19.9 358.1798 1.1 C24H23NO2 127, 144, 155,
230
Ma17 Ketone formation at pentyl side chain 20.2 356.1640 1.6 C24H21NO2 127, 144, 155,
228
Ma18 Ketone formation at pentyl side chain 22.4 356.1641 1.2 C24H21NO2 127, 144, 155,
228
Ma19 Hydroxylation at naphthalene moiety 24.3 358.1797 1.3 C24H23NO2 143, 171, 214
Ma20 Hydroxylation at naphthalene moiety 24.8 358.1797 1.2 C24H23NO2 143, 171, 214
Ma21 Dehydrogenation 28.7 340.1692 1.1 C24H21NO 127, 144, 155,
212
JWH-018 31.4 342.1851 0.5 C24H23NO 127, 144, 155,
214
a Position conﬁrmed by the use of reference standards.
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JWH-018, JWH-073 or AM2201 dissolved in 0.5 mL of methanol was added to the culture and incu-
bated for further 72 h [5]. Control experiments consisted of cultures without cannabinoids and ﬂasks
containing only media and cannabinoid [6,7].
2.3. Extraction, isolation, and identiﬁcation of metabolites
After 72 h of incubation, the contents of each ﬂask, including the controls, were ﬁltered through
Buchner funnel into a separating funnel and extracted with three aliquots of dichloromethane
(350 mL). The combined organic extracts were evaporated to dryness under vacuum at 40 °C using
a Buchi rotary evaporator (in vitro Technologies, Noble Park North, VIC, Australia) and placed under
high vacuum to remove traces of moisture. The residue was dissolved in acetonitrile to prepare
S. Watanabe et al. / Data in Brief 7 (2016) 332–340 3351 mg/mL stock solution and was ﬁltered through 0.22 mM syringe ﬁlter before analysis. Cannabinoid
parent drugs and metabolites were chromatographically separated using an Agilent Zorbax Eclipse
XDB-C18 analytical column (1504.6 mm, 5 μm). Mobile phases consisted of 0.1% formic acid in
water (mobile phase A) and acetonitrile (mobile phase B). The gradient used consisted of 30% B (0 to
2 min), linear gradient from 30% B to 50% B (2 to 5 min), 50% B to 90% B (5 to 30 min, hold for 5 min)
and 90% B to 30% B (35 to 40 min) run at 0.4 mL/min. MS data were acquired on an Agilent 6490 Triple
Quadrupole mass spectrometer with an electrospray ionization source (ESI) source (positive ion
mode), interfaced with an Agilent 1290 LC system. Samples prepared were injected in 2 mL volume to
obtain full scan and product ion scan spectra. Product ion scan experiments were conducted on
precursor ions that were presumed to be metabolites based on the comparison of full scan spectra of
the samples and controls. A fragmentor voltage of 380 V with discrete collision energy of 10, 20, 30
and 40 eV (for product ion scan) was applied. The scanning mass range was set atm/z 100–1000 (scan
time¼500 ms). The sheath gas temperature and ﬂow were set to 250 °C and 11 L/min, respectively.
The capillary and nozzle voltages were 3000 V and 1500 V, respectively.
High resolution quadrupole Time-of-Flight mass spectrometry (HRQToFMS) experiments were
carried out on an Agilent 6510 Accurate Mass QToF Mass Spectrometer, equipped with ESI source
operated in positive ion mode, in order to determine accurate masses of the metabolites. The LC
system and conditions used were the same as above. The following operation parameters were used:
injection volume 2 mL (full scan) and 10 mL (product ion scan); capillary voltage 3500 V; nebulizer
pressure 40 psi (275790 Pa); drying gas 10.0 L/min; gas temperature 350 °C; fragmentor voltage
160 V; collision energy 10, 20 and 40 eV; skimmer voltage 60 V. HRQToFMS accurate mass spectra
were recorded across the range from m/z 100 to m/z 1000. The mass axis was calibrated using the
mixture provided by the manufacturer over the m/z 50–3200 range. A second orthogonal sprayer
with a reference solution was used as a continuous calibration using the following reference masses:
m/z 121.0509 and m/z 922.0098. The chromatographic conditions and column used were same as
described above. The controls were subjected to the same analysis. Analysis of the chromatographic
and mass spectrometric data was conducted using MassHunter Workstation Software Qualitative
Analysis (version B.06.00, Agilent). Peaks present in the fungus sample, but not in the controls, wereTable 2
Key diagnostic product ions and their tentative structures used in elucidating biotransformation pathways of JWH-018 after C.
elegans incubation.
Biotransformation ID Key diagnostic product ions (m/z) and tentative
structures
Carboxylation at pentyl side chain Ma13 144: unchanged indole, 244: carboxylated pentylindole
Dehydrogenation at pentyl side chain Ma21 144: unchanged indole, 212: dehydrogenated N-
pentylindole
Dihydrodiol formation at naphthalene moiety Ma12 189: naphthalene with dihydrodiol
Dihydrodiol formation at naphthalene moie-
tyþhydroxylation at pentyl side chain
Ma2, Ma3 144: unchanged indole, 189: naphthalene with dihy-
drodiol, 230: hydroxylated N-pentylindole
Dihydrodiol formation at naphthalene moie-
tyþketone formation at pentyl side chain
Ma4, Ma5 189: naphthalene with dihydrodiol, 228: N-penty-
lindole with ketone
Dihydrodiol formation at naphthalene moietyþN-
dealkylation
Ma1 189: naphthalene with dihydrodiol
Dihydroxylation at pentyl side chain Ma7 144: unchanged indole, 246: dihydroxylated N-
pentylindole
Dihydroxylation at pentyl side chain and naph-
thalene moiety
Ma6, Ma8,
Ma9, Ma11
144: unchanged indole, 171: hydroxylated naphthalene,
230: hydroxylated N-pentylindole
Hydroxylation at naphthalene moiety Ma19, Ma20 171: hydroxylated naphthalene
Hydroxylation at pentyl side chain Ma14 –
Ma16
144: unchanged indole, 230: hydroxylated N-
pentylindole
Ketone formation at pentyl side chain Ma17, Ma18 144: unchanged indole, 228: N-pentylindole with
ketone
Ketone formation at pentyl side
chainþhydroxylation at naphthalene moiety
Ma10 144: unchanged indole, 171: hydroxylated naphthalene,
228: N-pentylindole with ketone
Table 3
Metabolites of JWH-073 after C. elegans incubation.
ID Biotransformation RT,
min
m/z
[MþH]þ
Mass accuracy
(ppm)
Formula Major product
ions
Mb1 Dihydrodiol formationþN-dealkylation 8.0 306.1123 0.5 C19H15NO3 143, 144, 171
Mb2 Dihydrodiol formationþhydroxylation at butyl side
chain
8.2 378.1700 0.1 C23H23NO4 143, 144, 171,
189, 216
Mb3 Dihydrodiol formationþhydroxylation at butyl side
chain
8.9 378.1690 2.6 C23H23NO4 143, 144, 171,
189, 216
Mb4 Dihydrodiol formationþketone formation at butyl
side chain
9.0 376.1543 0.1 C23H21NO4 143, 144, 171,
189, 214
Mb5 Dihydroxylation at butyl side chain 11.7 360.1594 0.0 C23H21NO3 127, 144, 155,
232
Mb6 Dihydroxylation at butyl side chain and naphtha-
lene moiety
12.1 360.1595 0.1 C23H21NO3 143, 144, 171,
216
Mb7 Dihydroxylation at butyl side chain and naphtha-
lene moiety
12.8 360.1594 0.1 C23H21NO3 143, 144, 171,
216
Mb8 Dihydrodiol formation 13.7 362.1751 0.1 C23H23NO3 143, 144, 171,
189, 200
Mb9 Ketone formation at butyl side chainþhydroxyla-
tion at naphthalene moiety
13.9 358.1438 0.0 C23H19NO3 143, 144, 171,
214
Mb10 Ketone formation at butyl side chainþhydroxyla-
tion at naphthalene moiety
14.5 358.1438 0.0 C23H19NO3 143, 144, 171,
214
Mb11 Carboxylation (N-butanoic acid)a 15.4 358.1437 0.1 C23H19NO3 127, 144, 155,
230
Mb12 Hydroxylation at butyl side chain (4-
hydroxybutyl)a
15.7 344.1645 0.2 C23H21NO2 127, 144, 155,
216
Mb13 Hydroxylation at butyl side chain (3-
hydroxybutyl)a
17.1 344.1646 0.3 C23H21NO2 127, 144, 155,
216
Mb14 Ketone formation at butyl side chain 19.5 342.1488 0.0 C23H19NO2 127, 144, 155,
214
Mb15 Hydroxylation at naphthalene moiety 21.5 344.1645 0.1 C23H21NO2 143, 144, 171,
200
Mb16 Hydroxylation at naphthalene moiety 22.0 344.1645 0.0 C23H21NO2 143, 144, 171,
200
Mb17 Dehydrogenation 25.7 326.1539 0.1 C23H19NO 127, 155, 198
JWH-073 28.8 328.1697 0.3 C23H21NO 127, 144, 155,
200
a Position conﬁrmed by the use of reference standards.
Table 4
Key diagnostic product ions and their tentative structures used in elucidating biotransformation pathways of JWH-073 after C.
elegans incubation.
Biotransformation ID Key diagnostic product ions (m/z) and tentative
structures
Carboxylation at butyl side chain Mb11 144: unchanged indole, 230: carboxylated butylindole
Dehydrogenation Mb17 198: dehydrogenated N-butylindole
Dihydrodiol formation at naphthalene moiety Mb8 189: naphthalene with dihydrodiol
Dihydrodiol formation at naphthalene moie-
tyþhydroxylation at butyl side chain
Mb2,
Mb3
144: unchanged indole, 189: naphthalene with dihy-
drodiol, 216: hydroxylated N-butylindole
Dihydrodiol formation at naphthalene moie-
tyþketone formation at butyl side chain
Mb4 144: unchanged indole, 189: naphthalene with dihy-
drodiol, 214: N-butylindole with ketone
Dihydrodiol formation at naphthalene moietyþN-
dealkylation
Mb1 171: hydroxylated naphthalene (resulting from naph-
thalene with dihydrodiol [2])
Dihydroxylation at butyl side chain Mb5 144: unchanged indole, 232: dihydroxylated N-
butylindole
Dihydroxylation at butyl chain and naphthalene
moiety
M6,
Mb7
144: unchanged indole, 171: hydroxylated naphthalene,
216: hydroxylated N-butylindole
Hydroxylation at butyl side chain Mb12,
Mb13
144: unchanged indole, 216: hydroxylated N-butylindole
Hydroxylation at naphthalene moiety Mb15,
Mb16
171: hydroxylated naphthalene
Ketone formation at butyl side chain Mb14 144: unchanged indole, 214: N-butylindole with ketone
Ketone formation at butyl side chainþhydroxylation
at naphthalene moiety
Mb9,
Mb10
144: unchanged indole, 171: hydroxylated naphthalene,
214: N-butylindole with ketone
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Table 5
Metabolites of AM2201 after C. elegans incubation.
ID Biotransformation RT,
min
m/z
[MþH]þ
Mass accu-
racy (ppm)
Formula Major product ions
Mc1 Dihydrodiol formationþN-dealkylation 8.0 306.1122 1.0 C19H15NO3 143, 144, 171, 189
Mc2 Dihydroxylation at pentyl side chain and
naphthalene moietyþglucosidation
8.2 554.2185 0.0 C30H32FNO8 143, 144, 171, 248,
392
Mc3 Dihydroxylation at pentyl side chain and
naphthalene moietyþglucosidation
8.4 554.2186 0.2 C30H32FNO8 143, 144, 171, 248,
392
Mc4 Oxidative deﬂuorinationþdihydrodiol forma-
tion (JWH-018 dihydrodiol-hydroxy)
8.5 392.1858 0.4 C24H25NO4 143, 171, 189, 230
Mc5 Dihydrodiol formationþhydroxylation at pen-
tyl side chain
8.5 410.1764 0.6 C24H24FNO4 143, 144, 171, 189,
248
Mc6 Dihydrodiol formationþhydroxylation at pen-
tyl side chain
8.7 410.1761 0.2 C24H24FNO4 143, 144, 171, 189,
248
Mc7 Dihydroxylation at pentyl side chain and/or
indole moietyþglucosidation
9.0 554.2186 0.3 C30H32FNO8 127, 155, 264, 392
Mc8 Trihydroxylation at pentyl side chain, indole
moiety and naphthalene moiety
9.3 408.1606 0.1 C24H22FNO4 143, 160, 171, 264
Mc9 Dihydrodiol formationþdihydroxylation at
indole moiety
9.5 426.1712 0.1 C24H24FNO5 143, 171, 176, 189,
264
Mc10 Dihydrodiol formationþketone formation at
pentyl side chain
9.7 408.1606 0.0 C24H22FNO4 143, 171, 189, 246
Mc11 Trihydroxylation at pentyl side chain, indole
moiety and naphthalene moiety
10.2 408.1606 0.0 C24H22FNO4 143, 160, 171, 264
Mc12 Hydroxylation at indole moietyþglucosidation 10.5 538.2235 0.1 C30H32FNO7 127, 155, 160, 248,
376
Mc13 Dihydroxylation at pentyl side chain and/or
indole moietyþglucosidation
10.7 554.2183 0.3 C30H32FNO8 127, 155, 264, 392
Mc14 Hydroxylation at naphthalene
moietyþglucosidation
10.8 538.2234 0.4 C30H32FNO7 143, 144, 171, 232,
376
Mc15 Oxidative deﬂuorinationþhydroxylation at
indole moiety (JWH-018 dihydroxy)
11.1 374.1751 0.2 C24H23NO3 127, 155, 160, 246
Mc16 Dihydroxylation at naphthaleneþglucosidation 11.5 554.2182 0.4 C30H32FNO8 187, 232, 392
Mc17 Dihydroxylation at indole moiety and pentyl
side chain
11.5 392.1657 0.0 C24H22FNO3 127, 155, 160, 264
Mc18 Oxidative deﬂuorinationþhydroxylation at
indole moiety (JWH-018 dihydroxy)
11.8 374.1748 0.8 C24H23NO3 127, 155, 160, 246
Mc19 Dihydroxylation at indole moiety and pentyl
side chain
11.9 392.1656 0.2 C24H22FNO3 127, 155, 160, 264
Mc20 Oxidative deﬂuorination to carboxylic acid-
þhydroxylation at naphthalene moiety
12.0 388.1547 1.0 C24H21NO4 143, 144, 171, 244
Mc21 Oxidative deﬂuorinationþhydroxylation at
pentyl side chain (JWH-018 dihydroxy)
12.1 374.1751 0.2 C24H23NO3 127, 144, 155, 246
Mc22 Dihydroxylation at indole moiety and pentyl
side chain
12.2 392.1658 0.5 C24H22FNO3 127, 155, 160, 264
Mc23 Oxidative deﬂuorinationþhydroxylation at
naphthalene moiety (JWH-018 dihydroxy)
12.3 374.1749 0.4 C24H23NO3 143, 144, 171, 230
Mc24 Dihydroxylation at pentyl side chain and
naphthalene moiety
12.5 392.1651 1.4 C24H22FNO3 143, 144, 171, 248
Mc25 Dihydrodiol formation 12.5 394.1812 0.3 C24H24FNO3 143, 144, 171, 189,
232
Mc26 Oxidative deﬂuorination to carboxylic acid-
þhydroxylation at naphthalene moiety
12.7 388.1544 0.3 C24H21NO4 143, 144, 171, 244
Mc27 Dihydroxylation at indole moiety and pentyl
side chain
12.7 392.1657 0.0 C24H22FNO3 127, 155, 160, 264
Mc28 Oxidative deﬂuorinationþhydroxylation at
naphthalene moiety (JWH-018 dihydroxy)
12.9 374.1750 0.3 C24H23NO3 143, 144, 171, 230
Mc29 Dihydroxylation at pentyl side chain and
naphthalene moiety
13.0 392.1655 0.3 C24H22FNO3 143, 144, 171, 248
Mc30 Dihydrodiol formation 13.5 394.1818 1.2 C24H24FNO3 143, 144, 171, 189,
232
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Table 5 (continued )
ID Biotransformation RT,
min
m/z
[MþH]þ
Mass accu-
racy (ppm)
Formula Major product ions
Mc31 Dihydroxylation at pentyl side chain and
naphthalene moiety
13.6 392.1655 0.3 C24H22FNO3 143, 144, 171, 248
Mc32 Dihydroxylation at pentyl side chain and
naphthalene moiety
14.4 392.1659 0.6 C24H22FNO3 143, 144, 171, 248
Mc33 Oxidative deﬂuorination to carboxylic acid
(JWH-018 N-pentanoic acid)a
16.4 372.1592 0.7 C24H21NO3 127, 144, 155, 244
Mc34 Oxidative deﬂuorination (JWH-018 N-(5-
hydroxypentyl))a
17.1 358.1802 0.2 C24H23NO2 127, 144, 155, 230
Mc35 Hydroxylation at pentyl side chain 17.3 376.1709 0.4 C24H22FNO2 127, 144, 155, 248
Mc36 Hydroxylation at indole moiety 17.7 376.1707 0.2 C24H22FNO2 127, 155, 160, 248
Mc37 Hydroxylation at pentyl side chain 18.0 376.1708 0.1 C24H22FNO2 127, 144, 155, 248
Mc38 Dihydroxylation at naphthalene
moietyþsulfation
18.7 472.1222 0.6 C24H22FNO6S 144, 158, 159, 186,
187, 232, 391, 392
Mc39 Hydroxylation at pentyl side chain 18.8 376.1708 0.3 C24H22FNO2 127, 144, 155, 248
Mc40 Hydroxylation at naphthalene moiety 19.2 376.1709 0.6 C24H22FNO2 143, 144, 171, 232
Mc41 Hydroxylation at naphthalene moiety 19.8 376.1703 1.2 C24H22FNO2 143, 144, 171, 232
Mc42 Dihydroxylation at naphthalene
moietyþsulfation
20.2 472.1224 0.1 C24H22FNO6S 144, 158, 159, 186,
187, 232, 391, 392
Mc43 Ketone formation at pentyl side chain 20.4 374.1549 0.5 C24H20FNO2 127, 144, 155, 246
Mc44 Hydroxylation at naphthalene moiety 20.6 376.1706 0.3 C24H22FNO2 143, 144, 171, 232
Mc45 Hydroxylation at naphthalene moiety 21.3 376.1707 0.1 C24H22FNO2 143, 144, 171, 232
Mc46 Dihydroxylation at indole moietyþsulfation 22.0 472.1223 0.3 C24H22FNO6S 127, 155, 175, 176,
264, 391, 392
AM2201 25.6 360.1759 0.2 C24H22FNO 127, 144, 155, 232
Mc47 DeﬂuorinationþDemethylation (JWH-073)a 28.8 328.1695 0.3 C23H21NO 127, 144, 155, 200
Mc48 Deﬂuorination (JWH-018)a 31.5 342.1853 0.0 C24H23NO 127, 144, 155, 214
a Position conﬁrmed by the use of reference standards.
Table 6
Key diagnostic product ions and their tentative structures used in elucidating biotransformation pathways of AM2201 after C.
elegans incubation. Square brackets indicate phase II metabolism.
Biotransformation ID Key diagnostic product ions (m/z) and tentative
structures
Deﬂuorination (JWH-018) Mc48 155: unchanged naphthalene, 214: unchanged N-
pentylindole
DeﬂuorinationþDemethylation (JWH-
073)
Mc47 155: unchanged naphthalene, 200: unchanged N-
butylindole
Dihydrodiol formation at naphthalene
moiety
Mc25, Mc30 189: naphthalene with dihydrodiol
Dihydrodiol formation at naphthalene
moietyþdihydroxylation at indole
moiety
Mc9 176: dihydroxylated indole, 189: naphthalene with
dihydrodiol
Dihydrodiol formation at naphthalene
moietyþhydroxylation at pentyl side
chain
Mc5, Mc6 144: unchanged indole, 189: naphthalene with dihy-
drodiol, 248: hydroxylated N-ﬂuoropentylindole
Dihydrodiol formation at naphthalene
moietyþketone formation at pentyl
side chain
Mc10 144: unchanged indole, 189: naphthalene with dihy-
drodiol, 246: N-ﬂuoropentylindole with ketone
Dihydrodiol formation at naphthalene
moietyþN-dealkylation
Mc1 189: naphthalene with dihydrodiol
Dihydroxylation at indole moiety
[þsulfation]
[Sulfate Mc46] 176: dihydroxylation at indole, [392: dihydroxylated
AM2201]
Dihydroxylation at indole moiety and
pentyl side chain
Mc17, Mc19, Mc22,
Mc27
160: hydroxylated indole, 264: dihydroxylated N-
ﬂuoropentylindole
Dihydroxylation at naphthalene moiety
[þglucosidation and sulfation]
[Glucoside Mc16, sul-
fates Mc38, Mc42]
187: dihydroxylated naphthalene, [392: dihydroxylated
AM2201]
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Table 6 (continued )
Biotransformation ID Key diagnostic product ions (m/z) and tentative
structures
Dihydroxylation at naphthalene moiety
and pentyl side chain
[þglucosidation]
Mc24, Mc29, Mc31,
Mc32, [glucosides Mc2,
Mc3]
144: unchanged indole, 171: hydroxylated naphthalene,
248: hydroxylated N-ﬂuoropentylindole, [392: dihy-
droxylated AM2201]
Dihydroxylation at pentyl side chain
and/or indole moiety
[þglucosidation]
[glucosides Mc7, Mc13] 264: dihydroxylated N-ﬂuoropentylindole, [392: dihy-
droxylated AM2201]
Hydroxylation at indole moiety
[þglucosidation]
Mc36, [glucoside
Mc12]
160: hydroxylated indole, 248: hydroxylated N-ﬂuor-
opentylindole, [376: hydroxylated AM2201]
Hydroxylation at naphthalene moiety
[þglucosidation]
Mc40, Mc41, Mc44,
Mc45, [glucoside
Mc14]
171: hydroxylated naphthalene, [376: hydroxylated
AM2201]
Hydroxylation at pentyl side chain Mc35, Mc37 and Mc39 144: unchanged indole, 248: hydroxylated N-
ﬂuoropentylindole
Ketone formation at pentyl side chain Mc43 144: unchanged indole, 246: N-ﬂuoropentylindole with
ketone
Oxidative deﬂuorination (JWH-018 N-
(5-hydroxypentyl))
Mc34 144: unchanged indole, 230: hydroxylated N-
pentylindole
Oxidative deﬂuorinationþdihydrodiol
formation (JWH-018 dihydrodiol-
hydroxy)
Mc4 189: naphthalene with dihydrodiol, 230: hydroxylated
N-pentylindole
Oxidative deﬂuorinationþhydroxyla-
tion at indole moiety (JWH-018
dihydroxy)
Mc15, Mc18 160: hydroxylated indole, 246: dihydroxylated N-
pentylindole
Oxidative deﬂuorinationþhydroxyla-
tion at naphthalene moiety (JWH-018
dihydroxy)
Mc23, Mc28 144: unchanged indole, 171: hydroxylated naphthalene,
230: hydroxylated N-pentylindole
Oxidative deﬂuorinationþhydroxyla-
tion at pentyl side chain (JWH-018
dihydroxy)
Mc21 144: unchanged indole, 246: dihydroxylated N-
pentylindole
Oxidative deﬂuorination to carboxylic
acid (JWH-018 N-pentanoic acid)
Mc33 144: unchanged indole, 244: carboxylated pentylindole
Oxidative deﬂuorination to carboxylic
acidþhydroxylation at naphthalene
moiety.
Mc20, Mc26 144: unchanged indole, 171: hydroxylated naphthalene,
244: carboxylated pentylindole
Trihydroxylation at indole moiety,
naphthalene moiety and pentyl side
chain
Mc8, Mc11 160: hydroxylated indole, 171: hydroxylated naphtha-
lene, 264: dihydroxylated N-ﬂuoropentylindole
S. Watanabe et al. / Data in Brief 7 (2016) 332–340 339manually identiﬁed and their fragmentation patterns and accurate masses were examined to identify
the metabolites. The signal-to-noise ratio of all the identiﬁed metabolites was greater than 5.Appendix A. Supplementary material
Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2016.02.039.References
[1] S. Watanabe, U. Kuzhiumparambil, Z. Winiarski, S. Fu, Biotransformation of synthetic cannabinoids JWH-018, JWH-073 and
AM2201 by Cunninghamella elegans, Forensic Sci. Int. 261 (2016) 33–42.
[2] T. Sobolevsky, I. Prasolov, G. Rodchenkov, Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic
cannabinoids, Drug Test. Anal. 4 (2012) 745–753. http://dx.doi.org/10.1002/dta.1418.
[3] S. Nunomoto, Y. Kawakami, Y. Yamashita, H. Takeuchi, S. Eguchi, Regioselectivity control in alkylation reactions of indolyl
ambident anion, J. Chem. Soc. Perkin Trans. 1 (1990) 111–114. http://dx.doi.org/10.1039/P19900000111.
S. Watanabe et al. / Data in Brief 7 (2016) 332–340340[4] T. Okauchi, M. Itonaga, T. Minami, T. Owa, K. Kitoh, H. Yoshino, A general method for acylation of indoles at the 3-position
with acyl chlorides in the presence of dialkylaluminum chloride, Org. Lett. 2 (2000) 1485–1487. http://dx.doi.org/10.1021/
ol005841p.
[5] M.I. Choudhary, N.T. Khan, S.G. Musharraf, S. Anjum, R. Atta ur, Biotransformation of adrenosterone by ﬁlamentous fungus,
Cunninghamella elegans, Steroids 72 (2007) 923–929. http://dx.doi.org/10.1016/j.steroids.2007.08.002.
[6] M.I. Choudhary, Z.A. Siddiqui, S.G. Musharraf, S.A. Nawaz, R. Atta Ur, Microbial transformation of prednisone, Nat. Prod. Res.
19 (2005) 311–317. http://dx.doi.org/10.1080/14786410410001729168.
[7] A. Rydevik, M. Thevis, O. Krug, U. Bondesson, M. Hedeland, The fungus Cunninghamella elegans can produce human and
equine metabolites of selective androgen receptor modulators (SARMs), Xenobiotica 43 (2013) 409–420. http://dx.doi.org/
10.3109/00498254.2012.729102.
